Syntheses and Pharmacokinetic Studies of Prodrug Esters for the Development of Oral Carbapenem, L-084

We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1 R ,5 S ,6 S )-6-[( R )-1-hydroxyethyl]-1-methyl-2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity ag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2006-04, Vol.59 (4), p.241-247
Hauptverfasser: Isoda, Takeshi, Ushirogochi, Hideki, Satoh, Koichi, Takasaki, Tsuyoshi, Yamamura, Itsuki, Sato, Chisato, Mihira, Ado, Abe, Takao, Tamai, Satoshi, Yamamoto, Shigeki, Kumagai, Toshio, Nagao, Yoshimitsu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1 R ,5 S ,6 S )-6-[( R )-1-hydroxyethyl]-1-methyl-2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity against Gram-positive and Gram-negative bacteria and exhibited the highest intestinal absorption among synthesized prodrugs of LJC11,036.
ISSN:0021-8820
1881-1469
DOI:10.1038/ja.2006.34